Serine/threonine/tyrosine kinase 1 drives pancreatic carcinogenesis via GSK3β sequestration-mediated Wnt/β-catenin pathway hyperactivation
Abstract The Wnt/β-catenin pathway is strongly relevant to pancreatic cancer progression, poor prognostic outcomes, and elevated cancer-related mortality. However, the mechanism underlying continuously activated Wnt/β-catenin signaling in pancreatic cancer, a context in which adenomatous polyposis c...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-06-01
|
| Series: | Signal Transduction and Targeted Therapy |
| Online Access: | https://doi.org/10.1038/s41392-025-02292-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849767065589645312 |
|---|---|
| author | Cefan Zhou Xueying Dong Shi Li Yue Xi Yuan Liu Xuehong Qian Ziyan Song Li Zhou Rui Zhang Hao Lyu Shuai Xiao Dong Guo Qi Zhang Weiyong Liu Yan Xiong Zhentian Wang Chaojun Yan Zijian Zhang Haichuan Zhu Xing-Zhen Chen Zhiyin Song Jingfeng Tang |
| author_facet | Cefan Zhou Xueying Dong Shi Li Yue Xi Yuan Liu Xuehong Qian Ziyan Song Li Zhou Rui Zhang Hao Lyu Shuai Xiao Dong Guo Qi Zhang Weiyong Liu Yan Xiong Zhentian Wang Chaojun Yan Zijian Zhang Haichuan Zhu Xing-Zhen Chen Zhiyin Song Jingfeng Tang |
| author_sort | Cefan Zhou |
| collection | DOAJ |
| description | Abstract The Wnt/β-catenin pathway is strongly relevant to pancreatic cancer progression, poor prognostic outcomes, and elevated cancer-related mortality. However, the mechanism underlying continuously activated Wnt/β-catenin signaling in pancreatic cancer, a context in which adenomatous polyposis coli (APC) mutations are rarely observed, remains poorly understood. In this study, we investigated the role of STYK1 in regulating canonical Wnt/β-catenin signaling and pancreatic cancer tumorigenesis using the LSL-Kras G12D ; Trp53 R172H/+ ; Pdx1 Cre mouse model. Our findings demonstrate that STYK1 directly binds to β-catenin and GSK3β, inhibiting GSK3β activity by increasing the level of its kinase-inactive form, which is phosphorylated at S9, and promoting its sequestration into MVBs. We further showed that STYK1-mediated GSK3β sequestration is impaired by autophagy inhibitors or in ATG7 knockout cells, linking this process to autophagic regulation. Structural analysis identified conserved tyrosine-based (Y191QRL194) and dileucine-based (GDLL203-204) sorting motifs in STYK1, which facilitate clathrin/AP2-dependent internalization essential for GSK3β sequestration. The phosphorylation of STYK1 at Y191 by BLK kinase enhances its interaction with AP2, thereby accelerating GSK3β sequestration and subsequent Wnt/β-catenin pathway activation. Notably, inhibitory peptides targeting either the STYK1-β-catenin or the STYK1-GSK3β interface significantly suppressed pancreatic cancer development in vitro and in vivo, underscoring their therapeutic potential. Collectively, these results elucidate a novel STYK1-driven mechanism for Wnt/β-catenin activation in APC-independent pancreatic cancer and provide preclinical evidence for targeting STYK1-mediated signaling as a therapeutic strategy. |
| format | Article |
| id | doaj-art-63434dc88e4748c4aaf7405d54f878e9 |
| institution | DOAJ |
| issn | 2059-3635 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Nature Publishing Group |
| record_format | Article |
| series | Signal Transduction and Targeted Therapy |
| spelling | doaj-art-63434dc88e4748c4aaf7405d54f878e92025-08-20T03:04:21ZengNature Publishing GroupSignal Transduction and Targeted Therapy2059-36352025-06-0110111810.1038/s41392-025-02292-xSerine/threonine/tyrosine kinase 1 drives pancreatic carcinogenesis via GSK3β sequestration-mediated Wnt/β-catenin pathway hyperactivationCefan Zhou0Xueying Dong1Shi Li2Yue Xi3Yuan Liu4Xuehong Qian5Ziyan Song6Li Zhou7Rui Zhang8Hao Lyu9Shuai Xiao10Dong Guo11Qi Zhang12Weiyong Liu13Yan Xiong14Zhentian Wang15Chaojun Yan16Zijian Zhang17Haichuan Zhu18Xing-Zhen Chen19Zhiyin Song20Jingfeng Tang21National “111” Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei University of TechnologyNational “111” Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei University of TechnologyNational “111” Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei University of TechnologyNational “111” Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei University of TechnologyNational “111” Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei University of TechnologyNational “111” Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei University of TechnologyNational “111” Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei University of TechnologyAnimal Biosafety Level III Laboratory at the Center for Animal Experiment, Wuhan UniversityNational “111” Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei University of TechnologyNational “111” Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei University of TechnologyNational “111” Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei University of TechnologyNational “111” Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei University of TechnologyNational “111” Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei University of TechnologyDepartment of Clinical Laboratory, Tongji Hospital, Huazhong University of Science and TechnologyZhongnan Hospital of Wuhan University, Institute of Hepatobiliary Diseases of Wuhan University, Transplant Center of Wuhan University, National Quality Control Center for Donated Organ Procurement, Hubei Key Laboratory of Medical Technology on Transplantation, Hubei Clinical Research Center for Natural Polymer Biological Liver, Hubei Engineering Center of Natural Polymer-based Medical MaterialsDepartment of Systems Biology for Medicine, School of Basic Medical Sciences, Fudan University, and Shanghai Fifth People’s Hospital, Fudan UniversityNational “111” Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei University of TechnologyNational “111” Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei University of TechnologyNational “111” Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei University of TechnologyMembrane Protein Disease Research Group, Department of Physiology, Faculty of Medicine and Dentistry, University of AlbertaDepartment of Pathology, School of Basic Medicine, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Huazhong University of Science and TechnologyNational “111” Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei University of TechnologyAbstract The Wnt/β-catenin pathway is strongly relevant to pancreatic cancer progression, poor prognostic outcomes, and elevated cancer-related mortality. However, the mechanism underlying continuously activated Wnt/β-catenin signaling in pancreatic cancer, a context in which adenomatous polyposis coli (APC) mutations are rarely observed, remains poorly understood. In this study, we investigated the role of STYK1 in regulating canonical Wnt/β-catenin signaling and pancreatic cancer tumorigenesis using the LSL-Kras G12D ; Trp53 R172H/+ ; Pdx1 Cre mouse model. Our findings demonstrate that STYK1 directly binds to β-catenin and GSK3β, inhibiting GSK3β activity by increasing the level of its kinase-inactive form, which is phosphorylated at S9, and promoting its sequestration into MVBs. We further showed that STYK1-mediated GSK3β sequestration is impaired by autophagy inhibitors or in ATG7 knockout cells, linking this process to autophagic regulation. Structural analysis identified conserved tyrosine-based (Y191QRL194) and dileucine-based (GDLL203-204) sorting motifs in STYK1, which facilitate clathrin/AP2-dependent internalization essential for GSK3β sequestration. The phosphorylation of STYK1 at Y191 by BLK kinase enhances its interaction with AP2, thereby accelerating GSK3β sequestration and subsequent Wnt/β-catenin pathway activation. Notably, inhibitory peptides targeting either the STYK1-β-catenin or the STYK1-GSK3β interface significantly suppressed pancreatic cancer development in vitro and in vivo, underscoring their therapeutic potential. Collectively, these results elucidate a novel STYK1-driven mechanism for Wnt/β-catenin activation in APC-independent pancreatic cancer and provide preclinical evidence for targeting STYK1-mediated signaling as a therapeutic strategy.https://doi.org/10.1038/s41392-025-02292-x |
| spellingShingle | Cefan Zhou Xueying Dong Shi Li Yue Xi Yuan Liu Xuehong Qian Ziyan Song Li Zhou Rui Zhang Hao Lyu Shuai Xiao Dong Guo Qi Zhang Weiyong Liu Yan Xiong Zhentian Wang Chaojun Yan Zijian Zhang Haichuan Zhu Xing-Zhen Chen Zhiyin Song Jingfeng Tang Serine/threonine/tyrosine kinase 1 drives pancreatic carcinogenesis via GSK3β sequestration-mediated Wnt/β-catenin pathway hyperactivation Signal Transduction and Targeted Therapy |
| title | Serine/threonine/tyrosine kinase 1 drives pancreatic carcinogenesis via GSK3β sequestration-mediated Wnt/β-catenin pathway hyperactivation |
| title_full | Serine/threonine/tyrosine kinase 1 drives pancreatic carcinogenesis via GSK3β sequestration-mediated Wnt/β-catenin pathway hyperactivation |
| title_fullStr | Serine/threonine/tyrosine kinase 1 drives pancreatic carcinogenesis via GSK3β sequestration-mediated Wnt/β-catenin pathway hyperactivation |
| title_full_unstemmed | Serine/threonine/tyrosine kinase 1 drives pancreatic carcinogenesis via GSK3β sequestration-mediated Wnt/β-catenin pathway hyperactivation |
| title_short | Serine/threonine/tyrosine kinase 1 drives pancreatic carcinogenesis via GSK3β sequestration-mediated Wnt/β-catenin pathway hyperactivation |
| title_sort | serine threonine tyrosine kinase 1 drives pancreatic carcinogenesis via gsk3β sequestration mediated wnt β catenin pathway hyperactivation |
| url | https://doi.org/10.1038/s41392-025-02292-x |
| work_keys_str_mv | AT cefanzhou serinethreoninetyrosinekinase1drivespancreaticcarcinogenesisviagsk3bsequestrationmediatedwntbcateninpathwayhyperactivation AT xueyingdong serinethreoninetyrosinekinase1drivespancreaticcarcinogenesisviagsk3bsequestrationmediatedwntbcateninpathwayhyperactivation AT shili serinethreoninetyrosinekinase1drivespancreaticcarcinogenesisviagsk3bsequestrationmediatedwntbcateninpathwayhyperactivation AT yuexi serinethreoninetyrosinekinase1drivespancreaticcarcinogenesisviagsk3bsequestrationmediatedwntbcateninpathwayhyperactivation AT yuanliu serinethreoninetyrosinekinase1drivespancreaticcarcinogenesisviagsk3bsequestrationmediatedwntbcateninpathwayhyperactivation AT xuehongqian serinethreoninetyrosinekinase1drivespancreaticcarcinogenesisviagsk3bsequestrationmediatedwntbcateninpathwayhyperactivation AT ziyansong serinethreoninetyrosinekinase1drivespancreaticcarcinogenesisviagsk3bsequestrationmediatedwntbcateninpathwayhyperactivation AT lizhou serinethreoninetyrosinekinase1drivespancreaticcarcinogenesisviagsk3bsequestrationmediatedwntbcateninpathwayhyperactivation AT ruizhang serinethreoninetyrosinekinase1drivespancreaticcarcinogenesisviagsk3bsequestrationmediatedwntbcateninpathwayhyperactivation AT haolyu serinethreoninetyrosinekinase1drivespancreaticcarcinogenesisviagsk3bsequestrationmediatedwntbcateninpathwayhyperactivation AT shuaixiao serinethreoninetyrosinekinase1drivespancreaticcarcinogenesisviagsk3bsequestrationmediatedwntbcateninpathwayhyperactivation AT dongguo serinethreoninetyrosinekinase1drivespancreaticcarcinogenesisviagsk3bsequestrationmediatedwntbcateninpathwayhyperactivation AT qizhang serinethreoninetyrosinekinase1drivespancreaticcarcinogenesisviagsk3bsequestrationmediatedwntbcateninpathwayhyperactivation AT weiyongliu serinethreoninetyrosinekinase1drivespancreaticcarcinogenesisviagsk3bsequestrationmediatedwntbcateninpathwayhyperactivation AT yanxiong serinethreoninetyrosinekinase1drivespancreaticcarcinogenesisviagsk3bsequestrationmediatedwntbcateninpathwayhyperactivation AT zhentianwang serinethreoninetyrosinekinase1drivespancreaticcarcinogenesisviagsk3bsequestrationmediatedwntbcateninpathwayhyperactivation AT chaojunyan serinethreoninetyrosinekinase1drivespancreaticcarcinogenesisviagsk3bsequestrationmediatedwntbcateninpathwayhyperactivation AT zijianzhang serinethreoninetyrosinekinase1drivespancreaticcarcinogenesisviagsk3bsequestrationmediatedwntbcateninpathwayhyperactivation AT haichuanzhu serinethreoninetyrosinekinase1drivespancreaticcarcinogenesisviagsk3bsequestrationmediatedwntbcateninpathwayhyperactivation AT xingzhenchen serinethreoninetyrosinekinase1drivespancreaticcarcinogenesisviagsk3bsequestrationmediatedwntbcateninpathwayhyperactivation AT zhiyinsong serinethreoninetyrosinekinase1drivespancreaticcarcinogenesisviagsk3bsequestrationmediatedwntbcateninpathwayhyperactivation AT jingfengtang serinethreoninetyrosinekinase1drivespancreaticcarcinogenesisviagsk3bsequestrationmediatedwntbcateninpathwayhyperactivation |